Lung Association’s ‘Turquoise Takeover’ spotlights screening

If you’ve witnessed turquoise lights gracing skyscrapers, buildings and landmarks this week, the American Lung Association hopes you don’t miss the message behind the show of color:

Remind a past or present lung smoker to get screened for lung cancer.

The exterior illuminations are only one part of the ALA’s annual “Turquoise Takeover” initiative. Also look for turquoise accents across social media, including in the apparel choices of enthusiasts posting selfies.

In an announcement posted May 10, Lung Association CEO Harold Wimmer explains:

“While lung cancer remains the leading cause of cancer deaths among both women and men, there is hope. The five-year survival rate increased by a dramatic 33% in the past 10 years. This is thanks, in part, to advancements in research and new treatments for the disease. Lung cancer screening is also a critical tool in our efforts to end lung cancer. That’s why, for this year’s Turquoise Takeover celebration, we are focusing our efforts on educating Americans on this lifesaving screening through our impactful new public service announcement, A Hope Story.”

Organizers of the weeklong event offer several ways to get involved, some of which are linked in ALA’s official announcement.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.